Dongkook Pharmaceutical Co 주식 주식분석 | 주식가격 | 뉴스 | 086450.KQ | KR7086450004 |

날짜	Dongkook Pharmaceutical Co 주식 가격
	16,620.00 undefined
	16,550.00 undefined
	16,750.00 undefined
	16,780.00 undefined
	17,090.00 undefined
	17,440.00 undefined
	17,460.00 undefined
	17,560.00 undefined
	17,440.00 undefined
	17,520.00 undefined
	17,580.00 undefined
	18,030.00 undefined
	16,370.00 undefined
	17,210.00 undefined
	17,000.00 undefined
	17,150.00 undefined
	17,750.00 undefined
	17,920.00 undefined
	18,000.00 undefined
	18,330.00 undefined
	18,400.00 undefined

날짜	Dongkook Pharmaceutical Co 매출	Dongkook Pharmaceutical Co EBIT	Dongkook Pharmaceutical Co 이익
2026e	981.55 조. undefined	105.5 조. undefined	78.68 조. undefined
2025e	896.11 조. undefined	93.19 조. undefined	74.64 조. undefined
2024e	813.32 조. undefined	81.2 조. undefined	66.29 조. undefined
2023	730.99 조. undefined	66.87 조. undefined	47.18 조. undefined
2022	661.65 조. undefined	72.65 조. undefined	52.9 조. undefined
2021	594.19 조. undefined	63.22 조. undefined	50.35 조. undefined
2020	559.1 조. undefined	84.73 조. undefined	55.93 조. undefined
2019	482.28 조. undefined	68.59 조. undefined	56.31 조. undefined
2018	400.81 조. undefined	55.12 조. undefined	46.95 조. undefined
2017	354.77 조. undefined	50.07 조. undefined	39.6 조. undefined
2016	309.69 조. undefined	46.93 조. undefined	40.66 조. undefined
2015	259.93 조. undefined	33.61 조. undefined	27.43 조. undefined
2014	226.01 조. undefined	26.55 조. undefined	21.1 조. undefined
2013	213.09 조. undefined	24.52 조. undefined	16.76 조. undefined
2012	180.3 조. undefined	27.06 조. undefined	22.31 조. undefined

	매출	EBIT	이익
2012	180.3 조. KRW	27.06 조. KRW	22.31 조. KRW
2013	213.09 조. KRW	24.52 조. KRW	16.76 조. KRW
2014	226.01 조. KRW	26.55 조. KRW	21.1 조. KRW
2015	259.93 조. KRW	33.61 조. KRW	27.43 조. KRW
2016	309.69 조. KRW	46.93 조. KRW	40.66 조. KRW
2017	354.77 조. KRW	50.07 조. KRW	39.6 조. KRW
2018	400.81 조. KRW	55.12 조. KRW	46.95 조. KRW
2019	482.28 조. KRW	68.59 조. KRW	56.31 조. KRW
2020	559.1 조. KRW	84.73 조. KRW	55.93 조. KRW
2021	594.19 조. KRW	63.22 조. KRW	50.35 조. KRW
2022	661.65 조. KRW	72.65 조. KRW	52.9 조. KRW
2023	730.99 조. KRW	66.87 조. KRW	47.18 조. KRW
2024e	813.32 조. KRW	81.2 조. KRW	66.29 조. KRW
2025e	896.11 조. KRW	93.19 조. KRW	74.64 조. KRW
2026e	981.55 조. KRW	105.5 조. KRW	78.68 조. KRW

2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
180.3	213.09	226.01	259.93	309.69	354.77	400.81	482.28	559.1	594.19	661.65	730.99	813.32	896.11	981.55
-	18.19	6.07	15.01	19.14	14.56	12.98	20.33	15.93	6.28	11.35	10.48	11.26	10.18	9.54
58.97	57.71	56.62	57.07	59.06	59.01	59.37	60.30	60.35	58.95	57.41	56.19	50.51	45.84	41.85
106.32	122.97	127.97	148.35	182.91	209.36	237.95	290.84	337.41	350.26	379.83	410.78	0	0	0
22.31	16.76	21.1	27.43	40.66	39.6	46.95	56.31	55.93	50.35	52.9	47.18	66.29	74.64	78.68
-	-24.87	25.85	29.99	48.25	-2.60	18.55	19.94	-0.69	-9.98	5.07	-10.81	40.51	12.60	5.41
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
44	44	44	44	44	44	44	45	45	44.72	44.72	44.73	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

35.71	49.3	63.52	89.13	102.38	116.41	152.29	174.19	168.93	103.95	93.71
80.67	82	87.79	88.18	102.43	101.68	105.73	123.49	124.93	134.41	162
0.78	6.55	7.81	7.08	9.4	12.5	11.38	13.49	14.57	17.19	17.06
32.64	31.47	32.52	45.24	50.7	63.51	60.87	79.05	102.59	120.15	138.34
2.83	3.84	3.54	4.37	6.28	6.33	8.75	8.55	9.21	9.62	8.08
152.62	173.16	195.18	233.99	271.19	300.43	339.02	398.76	420.23	385.32	419.2
44.36	53.4	56.94	62.79	69.43	140.74	158.07	194.97	234.94	263.36	272.7
12.66	8.88	13.13	15.71	21.46	28.52	36.36	48.24	72.22	88.73	112.64
0	0.1	0.1	2.16	2.09	2.09	0.64	6	6.01	6	6
4.27	3.97	4.2	4.23	4.33	4.36	4.24	7.3	6.92	10.87	16.16
1.33	1.05	1.05	1.05	0	0	0	0	0	0	0
3.01	3.6	4.2	5.16	4.81	4.11	6.05	7.89	9.77	14.04	12.83
65.64	71	79.62	91.1	102.12	179.82	205.36	264.4	329.85	383.01	420.34
218.26	244.17	274.8	325.1	373.31	480.25	544.38	663.16	750.08	768.33	839.54

22.23	22.23	22.23	22.23	22.23	22.62	22.62	22.62	22.62	22.62	22.62
12.06	12.06	12.06	12.06	3.29	13.02	12.9	13.05	13.21	13.04	15.57
125.17	142.92	166.39	203.89	239.58	278.41	328.38	376.73	419.76	467.18	507.32
1.25	1.25	1.25	1.25	1.25	1.25	1.25	1.25	1.25	1.33	1.38
1.35	0.85	0.84	1.03	0.73	0.87	0.87	0.87	0.87	0.87	0.87
162.06	179.31	202.76	240.45	267.08	316.16	366.01	414.51	457.7	505.03	547.75
14.12	17.14	18.11	21.05	20.26	18.06	17.06	26.52	29.17	33.41	62.07
3.12	3.39	3.88	3.47	4.33	4.05	4.78	5.26	6.07	5.96	6.88
23.57	27.75	29.88	43.23	46.07	55.1	71.09	96.77	100.79	95.24	77.68
0	0	0	0	0	15.17	15.02	13.85	82.19	36.95	48.23
2.91	4.49	6.96	5.14	9.52	0	2.07	22.49	24.38	26.98	36.3
43.73	52.77	58.83	72.89	80.18	92.37	110.01	164.9	242.6	198.54	231.15
0.7	1.6	1.49	0.48	0.36	40.12	43.2	52.12	13.69	27.45	20.22
0	0	0	0	0	0	0	3.29	5.77	4.81	4.85
11.59	13.23	13.87	13.39	13.27	16.15	5.75	7.06	6.38	6.47	7.14
12.29	14.83	15.35	13.87	13.63	56.27	48.95	62.46	25.83	38.73	32.21
56.02	67.6	74.19	86.76	93.81	148.63	158.96	227.36	268.43	237.27	263.36
218.07	246.91	276.94	327.21	360.89	464.79	524.98	641.87	726.14	742.3	811.11

2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
16.75	21	27.23	40.69	40.87	49.43	59.05	57.88	52.92	54.76
5.18	4.35	5.64	5.74	7.34	9.09	13.61	15.1	17.35	19.18
0	0	0	0	0	0	0	0	0	0
-12,104	-12,419	-18,061	-21,709	-31,495	-33,156	-23,061	-46,786	-42,251	-51,515
10.04	9.81	12.33	14.69	11.95	7.85	19.89	32.91	16.64	18.49
0.07	0.18	0.23	0.17	0.12	0.37	2.01	2.13	2.7	0.9
8.77	6.33	7.85	10.38	14.04	11.62	13.28	18.22	19.97	11.68
19.86	22.74	27.14	39.41	28.66	33.21	69.48	59.11	44.65	40.91
-4,641	-13,593	-9,595	-9,621	-11,888	-75,825	-25,185	-41,394	-51,421	-51,229
-11,223	-8,073	-17,261	-15,627	-17,413	-90,700	-55,838	-96,940	-43,530	-12,408
-6.58	5.52	-7.67	-6.01	-5.53	-14.88	-30.65	-55.55	7.89	38.82
0	0	0	0	0	0	0	0	0	0
0.49	2.48	2.33	-2.88	-3.54	45.42	-0.64	3.45	39.22	-32.41
-0.11	-2.83	0.76	0	1.88	12.4	1.6	28.47	0	0
-2.87	-1.33	0.73	-4.48	-3.31	56.07	-4.92	22.96	29.73	-39.79
0.1	1.5	0.28	1.03	1.86	2.82	-1.22	-1.81	-1.44	0.67
-3,353	-2,488	-2,638	-2,637	-3,516	-4,571	-4,651	-7,155	-8,049	-8,049
5.32	12.97	10.62	19.33	6.77	-1.33	8.46	-15.72	30.91	-11.75
15,219	9,144	17,548	29,791	16,771	-42,616	44,298	17,714	-6,767.5	-10,320.87
0	0	0	0	0	0	0	0	0	0

Dongkook Pharmaceutical Co 브루토마진	Dongkook Pharmaceutical Co 이익 마진	Dongkook Pharmaceutical Co EBIT-마진	Dongkook Pharmaceutical Co 이익 마진
2026e	56.19 %	10.75 %	8.02 %
2025e	56.19 %	10.4 %	8.33 %
2024e	56.19 %	9.98 %	8.15 %
2023	56.19 %	9.15 %	6.45 %
2022	57.41 %	10.98 %	7.99 %
2021	58.95 %	10.64 %	8.47 %
2020	60.35 %	15.16 %	10 %
2019	60.3 %	14.22 %	11.68 %
2018	59.37 %	13.75 %	11.71 %
2017	59.01 %	14.11 %	11.16 %
2016	59.06 %	15.15 %	13.13 %
2015	57.07 %	12.93 %	10.55 %
2014	56.62 %	11.75 %	9.33 %
2013	57.71 %	11.51 %	7.87 %
2012	58.97 %	15.01 %	12.38 %

	브루토마진	EBIT-마진	이익 마진
2012	58.97 %	15.01 %	12.38 %
2013	57.71 %	11.51 %	7.87 %
2014	56.62 %	11.75 %	9.33 %
2015	57.07 %	12.93 %	10.55 %
2016	59.06 %	15.15 %	13.13 %
2017	59.01 %	14.11 %	11.16 %
2018	59.37 %	13.75 %	11.71 %
2019	60.3 %	14.22 %	11.68 %
2020	60.35 %	15.16 %	10 %
2021	58.95 %	10.64 %	8.47 %
2022	57.41 %	10.98 %	7.99 %
2023	56.19 %	9.15 %	6.45 %
2024e	56.19 %	9.98 %	8.15 %
2025e	56.19 %	10.4 %	8.33 %
2026e	56.19 %	10.75 %	8.02 %

날짜	Dongkook Pharmaceutical Co 주당 매출	Dongkook Pharmaceutical Co EBIT 당 주식	Dongkook Pharmaceutical Co 주당 이익
2026e	22,324.07 undefined	0 undefined	1,789.38 undefined
2025e	20,380.72 undefined	0 undefined	1,697.47 undefined
2024e	18,497.84 undefined	0 undefined	1,507.59 undefined
2023	16,342.01 undefined	1,495.01 undefined	1,054.64 undefined
2022	14,794.1 undefined	1,624.5 undefined	1,182.73 undefined
2021	13,287.34 undefined	1,413.71 undefined	1,125.82 undefined
2020	12,424.51 undefined	1,882.98 undefined	1,242.78 undefined
2019	10,717.33 undefined	1,524.11 undefined	1,251.38 undefined
2018	9,109.25 undefined	1,252.61 undefined	1,067.02 undefined
2017	8,062.91 undefined	1,137.98 undefined	900.05 undefined
2016	7,038.41 undefined	1,066.5 undefined	924.09 undefined
2015	5,907.5 undefined	763.86 undefined	623.32 undefined
2014	5,136.68 undefined	603.5 undefined	479.5 undefined
2013	4,842.86 undefined	557.36 undefined	381 undefined
2012	4,097.64 undefined	614.93 undefined	507.09 undefined

	주당 매출	EBIT 당 주식	주당 이익
2012	4,097.64 KRW	614.93 KRW	507.09 KRW
2013	4,842.86 KRW	557.36 KRW	381 KRW
2014	5,136.68 KRW	603.5 KRW	479.5 KRW
2015	5,907.5 KRW	763.86 KRW	623.32 KRW
2016	7,038.41 KRW	1,066.5 KRW	924.09 KRW
2017	8,062.91 KRW	1,137.98 KRW	900.05 KRW
2018	9,109.25 KRW	1,252.61 KRW	1,067.02 KRW
2019	10,717.33 KRW	1,524.11 KRW	1,251.38 KRW
2020	12,424.51 KRW	1,882.98 KRW	1,242.78 KRW
2021	13,287.34 KRW	1,413.71 KRW	1,125.82 KRW
2022	14,794.1 KRW	1,624.5 KRW	1,182.73 KRW
2023	16,342.01 KRW	1,495.01 KRW	1,054.64 KRW
2024e	18,497.84 KRW	0 KRW	1,507.59 KRW
2025e	20,380.72 KRW	0 KRW	1,697.47 KRW
2026e	22,324.07 KRW	0 KRW	1,789.38 KRW

	주식 수량
2012	44 백만 Aktien
2013	44 백만 Aktien
2014	44 백만 Aktien
2015	44 백만 Aktien
2016	44 백만 Aktien
2017	44 백만 Aktien
2018	44 백만 Aktien
2019	45 백만 Aktien
2020	45 백만 Aktien
2021	44.72 백만 Aktien
2022	44.72 백만 Aktien
2023	44.73 백만 Aktien
2024e	44.73 백만 Aktien
2025e	44.73 백만 Aktien
2026e	44.73 백만 Aktien

날짜	Dongkook Pharmaceutical Co 배당금
2026e	196.06 undefined
2025e	196.06 undefined
2024e	196.03 undefined
2023	180 undefined
2022	180 undefined
2021	180 undefined
2020	180 undefined
2019	160 undefined
2018	104 undefined
2017	104 undefined
2016	80 undefined
2015	60 undefined
2014	60 undefined
2013	56 undefined
2012	76 undefined

	배당금	배당금 (추정)
2012	76 KRW	0 KRW
2013	56 KRW	0 KRW
2014	60 KRW	0 KRW
2015	60 KRW	0 KRW
2016	80 KRW	0 KRW
2017	104 KRW	0 KRW
2018	104 KRW	0 KRW
2019	160 KRW	0 KRW
2020	180 KRW	0 KRW
2021	180 KRW	0 KRW
2022	180 KRW	0 KRW
2023	180 KRW	0 KRW
2024e	0 KRW	196.03 KRW
2025e	0 KRW	196.06 KRW
2026e	0 KRW	196.06 KRW

날짜	Dongkook Pharmaceutical Co 배당률
2026e	15.34 %
2025e	15.31 %
2024e	15.48 %
2023	15.23 %
2022	15.22 %
2021	15.99 %
2020	14.48 %
2019	12.79 %
2018	9.75 %
2017	11.56 %
2016	8.66 %
2015	9.63 %
2014	12.51 %
2013	14.7 %
2012	14.99 %

	배당률
2012	14.99 %
2013	14.7 %
2014	12.51 %
2015	9.63 %
2016	8.66 %
2017	11.56 %
2018	9.75 %
2019	12.79 %
2020	14.48 %
2021	15.99 %
2022	15.22 %
2023	15.23 %
2024e	15.48 %
2025e	15.31 %
2026e	15.34 %

EPS-예상치	EPS-실제	보고 분기
335.31	298.6 (-10.95 %)	2020 Q2
294.09	369.8 (25.75 %)	2020 Q1
223.41	233.8 (4.65 %)	2018 Q1
279.16	291.6 (4.45 %)	2017 Q4

%-지분	이름	주식	변경
20.42663 %	Dongkook Healthcare Holdings Co.,Ltd.	8,981,245	0
19.72079 %	Kwon (Gi Beom)	8,670,900	0
6.38473 %	VIP Research & Management Inc.	2,807,258	445,555
5.67168 %	Fidelity Management & Research Company LLC	2,493,742	-1,045,556
3.71449 %	Kwon (Jae Beom)	1,633,200	0
3.45477 %	Norges Bank Investment Management (NBIM)	1,519,004	276,243
1.57141 %	The Vanguard Group, Inc.	690,922	-5,326
1.16820 %	Fidelity Institutional Asset Management	513,637	418,072
0.85532 %	Samsung Asset Management Co., Ltd.	376,070	358
0.76988 %	Dimensional Fund Advisors, L.P.	338,504	0
0.73304 %	BlackRock Institutional Trust Company, N.A.	322,304	1,375
0.60880 %	Kwon (Su Yeon)	267,680	0
0.51702 %	Kwon (Yun Jeong)	227,326	0
0.45707 %	Mirae Asset Global Investments Co., Ltd.	200,965	1,260
0.29273 %	Yun (Sun Ja)	128,710	0
0.21606 %	Shinyoung Asset Management	95,000	-3,089
0.18484 %	Kwon (Byeong Hun)	81,270	0
0.18113 %	BlackRock Advisors (UK) Limited	79,642	1,996
0.12326 %	Shinhan Asset Management Co Ltd	54,195	-1,819
0.10014 %	Charles Schwab Investment Management, Inc.	44,029	-390
0.09567 %	KB Asset Management Co., Ltd.	42,065	1,088
0.09454 %	California Public Employees' Retirement System	41,567	-1,957
0.08138 %	Baring Asset Management Korea Limited	35,781	6,623
0.06319 %	Dongkook Pharmaceutical Co., Ltd. Employees	27,785	0
0.06277 %	Dimensional Fund Advisors, Ltd.	27,598	0
0.04724 %	State Street Global Advisors (US)	20,771	-164
0.04617 %	Koreit Asset Management Co., Ltd.	20,300	-200
0.04597 %	Baring Asset Management, LLC.	20,212	2,755
0.04186 %	Mellon Investments Corporation	18,404	-484
0.03784 %	Nikko Asset Management Asia Limited	16,638	0
0.03113 %	Nuveen LLC	13,689	0
0.02976 %	American Century Investment Management, Inc.	13,083	9
0.02326 %	Kwon (Park)	10,225	0
0.01592 %	Kiwoom Asset Management Co., Ltd.	6,999	-294
0.01524 %	Niche Asset Management Limited	6,700	0
0.01362 %	State Street Global Advisors Ireland Limited	5,989	0
0.01251 %	Caisse de Depot et Placement du Quebec	5,500	5,500
0.00975 %	Korea Investment Management Co., Ltd.	4,286	115
0.00853 %	NH-Amundi Asset Management Co., Ltd.	3,752	-60
0.00833 %	State Street Global Advisors Ltd. (Canada)	3,661	-129
0.00749 %	IBK Asset Management Co., Ltd.	3,294	3,294
0.00613 %	Hanwha Asset Management Co., Ltd.	2,697	-836
0.00513 %	Daishin Asset Management Co., Ltd.	2,254	-278
0.00510 %	Eugene Asset Management Co., Ltd.	2,243	-4,856
0.00360 %	Midas International Asset Management Ltd.	1,584	-10,102
0.00342 %	DFA Australia Ltd.	1,503	-1
0.00323 %	Vanguard Global Advisers LLC	1,422	0
0.00250 %	HSBC Global Asset Management (UK) Limited	1,101	0
0.00197 %	Mackenzie Investments	868	0
0.00164 %	Northern Trust Investments, Inc.	720	0
0.00160 %	Irish Life Investment Managers Ltd.	704	0
0.00093 %	Invesco Capital Management LLC	408	-71
0.00073 %	DB Asset Management Co Ltd.	322	-1,524
0.00049 %	Avantis Investors	217	0
0.00038 %	Yurie Asset Management Inc.	169	127
0.00005 %	CI Global Asset Management	23	0
0 %	BNK Asset Management Co., Ltd.	0	-9,894
0 %	Plus Asset Management Company Ltd.	0	-17,826
0 %	Hyundai Asset Management Co., Ltd.	0	-4,363
0 %	Truston Asset Management Co., Ltd.	0	-703
0 %	Feynman Asset Management Co., Ltd.	0	-57,573
0 %	Korea Investment Value Asset Management Co., Ltd.	0	-20,141
0 %	VI Asset Management Korea Co. Ltd.	0	-320
0 %	Geode Capital Management, L.L.C.	0	-17,705
0 %	Matthews International Capital Management, L.L.C.	0	-90,730
0 %	Boston Partners	0	-903
0 %	Eastspring Investments (Singapore) Limited	0	-15,066
0 %	Welcome Asset Management Corporation	0	-341

What values and corporate philosophy does Dongkook Pharmaceutical Co represent?

Dongkook Pharmaceutical Co Ltd represents a commitment to improving healthcare and enhancing people's lives. Their corporate philosophy revolves around innovation, integrity, and customer-centricity. As a leading pharmaceutical company, Dongkook focuses on developing high-quality products and delivering exceptional services to meet the diverse needs of patients and healthcare professionals. With a strong emphasis on research and development, Dongkook Pharmaceutical Co Ltd continuously strives to contribute to advancements in the medical field. Through its unwavering dedication to excellence and putting customers at the forefront, Dongkook Pharmaceutical Co Ltd remains a trusted and respected name in the industry.

In which countries and regions is Dongkook Pharmaceutical Co primarily present?

Dongkook Pharmaceutical Co Ltd is primarily present in South Korea.

What significant milestones has the company Dongkook Pharmaceutical Co achieved?

Dongkook Pharmaceutical Co Ltd has achieved several significant milestones in its operation. The company has successfully established itself as a leading player in the pharmaceutical industry, both domestically and internationally. Dongkook Pharmaceutical Co Ltd has shown remarkable growth and innovation over the years, launching a wide range of high-quality healthcare products and medications. Additionally, the company has received numerous certifications and accolades for its commitment to excellence and adherence to stringent quality standards. With its relentless focus on research and development, Dongkook Pharmaceutical Co Ltd continues to make strides towards providing effective and efficient healthcare solutions to its customers worldwide.

What is the history and background of the company Dongkook Pharmaceutical Co?

Dongkook Pharmaceutical Co Ltd, a leading company in the pharmaceutical industry, has a rich history and background. Established in [year], Dongkook Pharmaceutical has been dedicated to improving people's health and well-being through innovative solutions. With a strong focus on research and development, the company has successfully launched a diverse range of pharmaceutical products that are trusted by both medical professionals and patients worldwide. Dongkook Pharmaceutical's commitment to quality, excellence, and customer satisfaction has made it a renowned player in the industry. With its continuous growth and expansion, Dongkook Pharmaceutical Co Ltd aims to enhance the quality of life for individuals globally.

Who are the main competitors of Dongkook Pharmaceutical Co in the market?

Dongkook Pharmaceutical Co Ltd faces competition from several key players in the market. Some notable competitors include CJ HealthCare Corp, SK Chemicals Co Ltd, and Daewoong Pharmaceutical Co Ltd. Each of these companies operates in the pharmaceutical industry and offers a range of products and services that may overlap with Dongkook Pharmaceutical Co Ltd's offerings. Despite facing competition, Dongkook Pharmaceutical Co Ltd strives to differentiate itself by highlighting its unique product portfolio, innovation, and commitment to quality.

In which industries is Dongkook Pharmaceutical Co primarily active?

Dongkook Pharmaceutical Co Ltd is primarily active in the pharmaceutical industry.

What is the business model of Dongkook Pharmaceutical Co?

Dongkook Pharmaceutical Co Ltd operates in the healthcare sector, specifically in the pharmaceutical industry. As a company, Dongkook Pharmaceutical focuses on the research, development, manufacturing, and marketing of various pharmaceutical products. With its innovative and technology-driven approach, Dongkook Pharmaceutical aims to enhance people's quality of life by providing effective and reliable medications. The company emphasizes its commitment to research and development, striving to introduce new and improved therapeutic options for various diseases and medical conditions. With a strong focus on quality and compliance, Dongkook Pharmaceutical aims to contribute to the advancement of healthcare and the well-being of individuals globally.

Dongkook Pharmaceutical Co 2024의 P/E 비율은 얼마입니까?

Dongkook Pharmaceutical Co의 P/E 비율은 11.22입니다.

Dongkook Pharmaceutical Co 2024의 KUV는 얼마입니까?

Dongkook Pharmaceutical Co의 P/S 비율은 0.91입니다.

Dongkook Pharmaceutical Co의 AlleAktien 품질 점수는 얼마인가요?

Dongkook Pharmaceutical Co에 대한 AlleAktien 품질 점수는 7/10입니다.

Dongkook Pharmaceutical Co 2024의 매출은 얼마인가요?

예상되는 Dongkook Pharmaceutical Co 매출은 813.32 조. KRW입니다.

Dongkook Pharmaceutical Co 2024의 이익은 얼마인가요?

예상되는 Dongkook Pharmaceutical Co 이익은 66.29 조. KRW입니다.

Dongkook Pharmaceutical Co은 무엇을 하나요?

Dongkook Pharmaceutical Co Ltd is a Korean company that specializes in the production and distribution of pharmaceuticals and medical devices. The company was founded in 1968 and is headquartered in Seoul, South Korea. Dongkook Pharmaceutical Co Ltd is a publicly traded company and is one of the largest pharmaceutical companies in Korea. The company is divided into three main sectors: pharmaceuticals, medical devices, and healthcare. Each of these divisions offers a range of products specifically tailored to the needs and requirements of customers. In the pharmaceuticals sector, Dongkook offers various products for the treatment of conditions such as hypertension, diabetes, asthma, allergies, and pain. The product range includes tablets, drops, sprays, ointments, injections, and high-quality biological medicines. In the medical devices sector, Dongkook offers high-quality devices and instruments used in medicine. These include blood pressure monitors, stethoscopes, ultrasound machines, endoscopes, and ventilators. These products are distributed to both hospitals and medical facilities, as well as individual customers. In the healthcare sector, Dongkook offers various dietary supplements, vitamins, and cosmetics. These products contribute to improving the health and well-being of customers. This includes multivitamin and mineral supplements, omega-3 and other dietary supplements, as well as skincare and haircare products. Dongkook Pharmaceutical Co Ltd's business model is based on high-quality products and excellent customer care. The company works closely with customers and partners to ensure that products meet their needs and requirements. The company employs highly qualified researchers and professionals who constantly work on developing new products and driving innovation. Dongkook Pharmaceutical Co Ltd aims to play a leading role in the global pharmaceutical industry. The company actively participates in international collaborations and partnerships to optimize the distribution and marketing of its products worldwide. The company has branches and distribution partners in Asia, Europe, North America, and other regions of the world. In conclusion, Dongkook Pharmaceutical Co Ltd is a leading company in the pharmaceutical industry, offering a wide range of pharmaceuticals, medical devices, and healthcare products to customers worldwide. The company relies on high quality and innovation to satisfy its customers and secure its leading position in the global pharmaceutical industry.

Dongkook Pharmaceutical Co 배당금은 얼마입니까?

Dongkook Pharmaceutical Co은(는) 연간 번의 배당을 통해 180 KRW의 배당금을 지급합니다.

Dongkook Pharmaceutical Co이 얼마나 자주 배당을 지급하나요?

Dongkook Pharmaceutical Co의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Dongkook Pharmaceutical Co ISIN이 무엇입니까?

Dongkook Pharmaceutical Co의 ISIN은 KR7086450004입니다.

Dongkook Pharmaceutical Co 티커는 무엇인가요?

Dongkook Pharmaceutical Co의 티커는 086450.KQ입니다.

Dongkook Pharmaceutical Co이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Dongkook Pharmaceutical Co은(는) 180 KRW 의 배당금을 지급했습니다. 이는 약 1.08 %의 배당 수익률에 해당합니다. 향후 12개월 동안 Dongkook Pharmaceutical Co은(는) 196.06 KRW의 배당금을 지급할 것으로 예상됩니다.